Allogene Therapeutics Announces February and March 2020 Investor Conference Schedule

NEXT STORY
Conduent Market-Leading Disease Surveillance and Outbreak Management System to Fight Coronavirus
PREV STORY
Generex Biotechnology Subsidiaries NuGenerex Immuno-Oncology and NuGenerex Diagnostics Working to Address the Coronavirus Pandemic and Emerging Risk of Avian Flu Using Ii-Key Peptide Vaccines
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FDA expands approval of Dupixent® (dupilumab) to include children aged 6 to 11 years with moderate-to-severe asthma

author_avatar
NASDAQ Market News

ASLAN Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News

Matinas BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

author_avatar
NASDAQ Market News